Pharma enews 2020 july
Topic 1 pharma july2020

World’s First in vivo COVID-19 Imaging Experiments

Biomedical research addresses the urgent need to know more about COVID-19 pneumonia. The KU Leuven, Belgium is playing a leading role in preclinical testing to study the efficacy of vaccine and drug candidates in COVID-19 infection models using the Bruker SkyScan 1278 in vivo micro-CT system. Read more

Topic 2 pharma july2020

Secure Electronic Records on Handheld Spectrometers?

Handheld Raman spectrometers enable fast and cost-effective raw materials testing and are getting more popular. However, especially handheld analyzers being mobile, stand-alone operated instruments generating electronic records, naturally bear the risk of data loss – just by the fact that e-records are recorded on a mobile unit. Bruker’s BRAVO is the sophisticated handheld Raman analyzer dedicated for the Pharmaceutical industry offering out-of-the-box compliance to the extensive regulatory requirements, including instantaneous backup of e-records and reporting options from the spectrometers to a Protected Data Pool – the answer of Bruker’s OPUS spectroscopy software suite to Data Integrity. Read more

Topic 3 pharma july2020

Novel In-house Structure of a Cognate Chaperone-Toxin Complex

Pseudomonas aeruginosa is widely known to be an emerging opportunistic gram-negative pathogen that harbors multiple virulence factors for manipulating a host’s cell signaling pathways and immune response1. This pathogen is also solely responsible for more than 10% of hospital acquired infections. Read more

Media Center

 

 

 

Topic 4 pharma july2020

Characterizing Pharmaceutical Formulations Using Solid-State NMR Spectroscopy

Live webinar on July 28, 2020: Dr. Eric J. Munson, Professor and Head Dane O. Kildsig Chair in Industrial and Physical Pharmacy will talk about advanced analytical techniques can provide unique insight into the composition and properties of pharmaceutical formulations.View here

Topic 5 pharma july2020

Comparability Studies of Pharmaceutical Proteins by 2D NMR Fingerprint

Recorded Webinar

Live webinar on September 8, 2020: An important aspect in analytical assessment of pharmaceutical proteins is the comprehensive characterization of their higher order structure (HOS). This project explores the use of 2D NMR spectroscopy for in-depth analyses of HOS of bioactive proteins. Watch it now!

Topic 6 pharma july2020

Secondary Structure Determination of Conserved SARS-CoV-2 RNA Elements by NMR Spectroscopy

On-demand webinar: The fight against the global pandemic caused by the SARSCoV2 virus is currently the greatest challenge for society and science. Christian Richter from GU Frankfurt discusses how he and his colleagues are part of the organization researching COVID19 with NMR. Watch it now!